Author of the publication

Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV

, , , , , , , , , , and . mAbs, 9 (5): 831-843 (2017)
DOI: 10.1080/19420862.2017.1319023

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells, , , , , and . Oncotarget, 9 (13): 11322--11335 (February 2018)IgG-single-chain TRAIL fusion proteins for tumour therapy, , , , , , , and . Scientific Reports, (2018)Superior properties of Fc-comprising scTRAIL fusion proteins, , , , , , , and . Molecular Cancer Therapeutics, 16 (12): molcanther.0551.2017 (December 2017)Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV, , , , , , , , , and 1 other author(s). mAbs, 9 (5): 831--843 (July 2017)A Fab-Selective Immunoglobulin-Binding Domain from Streptococcal Protein G with Improved Half-Life Extension Properties, , , and . PLOS ONE, 10 (10): e0139838 (2015)Molecular modelling of the mass density of single proteins, , and . Journal of Biomolecular Structure and Dynamics, 30 (3): 318-327 (2012)PBPK Modeling to Guide Experimental Design in Drug Development, , , , , , , , and . The American Conference on Pharmacometrics 2015 (ACoP6), 42, Suppl. 1, page S75. Dordrecht, Springer, (2015)PBPK-PD Modeling to provide a translational rationale between drugs and between species: example of trail fusion proteins, , , , , , , , , and . Abstracts / ASCPT 2016 Annual Meeting & Quantitative Translational Approaches in Oncology Pre-Conference, 99, Suppl. 1, page S70. Hoboken, NJ, Wiley-Blackwell, (2016)Multivalent antibody-scTRAIL fusion proteins for tumor therapy : impact of format and targeting. Universität Stuttgart, Stuttgart, Dissertation, (2017)IgG-single-chain TRAIL fusion proteins for tumour therapy, , , , , , , and . Scientific Reports, 8 (1): 7808 (December 2018)